Nemus Bioscience Inc Stock OTC Bulletin Board
Equities
Biotechnology & Medical Research
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 361M |
---|---|---|---|---|---|
Net income 2024 * | -23M | Net income 2025 * | -34M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-16.4
x | P/E ratio 2025 * |
-14.7
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 92.92% |
Managers | Title | Age | Since |
---|---|---|---|
Punit Dhillon
CEO | Chief Executive Officer | 44 | 18-01-18 |
Director of Finance/CFO | - | 21-10-04 | |
Chief Tech/Sci/R&D Officer | 52 | 22-12-12 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 77 | 20-08-06 | |
Praveen Tyle
BRD | Director/Board Member | 64 | 21-07-21 |
Andrew Schwab
BRD | Director/Board Member | 53 | 23-08-17 |
1st Jan change | Capi. | |
---|---|---|
+1.12% | 42.59B | |
+6.77% | 40.65B | |
+45.26% | 40.57B | |
-11.96% | 26.77B | |
+6.01% | 24.81B | |
-24.92% | 18.17B | |
-3.63% | 11.7B | |
+27.16% | 12.05B | |
+7.30% | 11.1B |